Skip to main content

Associate Professor of Medicine Associate Chief of Hematology, Basic and Translational Research Medical Director, Advanced Cellular Therapeutics Facility Director, Bone Marrow Transplant Program

Castle Connolly Top Doctor Logo

Areas of Interest

Bone marrow and stem cell transplantation, Hematologic malignancies, Cancer immunotherapy, Cancer antigen discovery


Paul Armistead MD, PhD, is a physician scientist and a member of the UNC Program in Bone Marrow Transplant and Cellular Therapy. He has a clinical interest in the application of stem cell transplantation and other cellular therapies in the treatment of hematologic malignancies including leukemia, lymphoma and multiple myeloma, with a primary focus on acute myeloid leukemia (AML). His clinical research involves the evaluation of novel immunotherapies in the treatment of hematologic malignancies and the development of methods for the detection of minimal residual disease in AML patients

Dr. Armistead’s laboratory interests are primarily in the area of cancer antigen discovery and the development of immunotherapeutics targeting these antigens. His research group has identified multiple leukemia antigens. In collaboration with other researchers at UNC, immunotherapeutics, both cellular therapies and vaccines, are being developed against two of the most promising targets. Continuing research focuses involve expanding the number of discovered antigens to enable the development of therapeutics that can treat increasing numbers of patients.

Education and Training

  • Undergraduate University of North Carolina at Chapel Hill
  • Medical School University of North Carolina at Chapel Hill
  • PhD. Chemistry University of North Carolina at Chapel Hill
  • Residency Brigham and Women’s Hospital
  • Fellowship M.D. Anderson Cancer Center